about
Myeloid malignancies: mutations, models and managementUse of single nucleotide polymorphism array technology to improve the identification of chromosomal lesions in leukemiaChromosomal minimal critical regions in therapy-related leukemia appear different from those of de novo leukemia by high-resolution aCGH.miR-22 has a potent anti-tumour role with therapeutic potential in acute myeloid leukaemiaThe NF1 somatic mutational landscape in sporadic human cancers.The NF1 gene revisited - from bench to bedside.Assessing karyotype precision by microarray-based comparative genomic hybridization in the myelodysplastic/myeloproliferative syndromesAcquired genomic copy number aberrations and survival in adult acute myelogenous leukemiaIntegration of SNP and mRNA arrays with microRNA profiling reveals that MiR-370 is upregulated and targets NF1 in acute myeloid leukemia.Modulation of Ras signaling alters the toxicity of hydroquinone, a benzene metabolite and component of cigarette smoke.Strategy for robust detection of insertions, deletions, and point mutations in CEBPA, a GC-rich content gene, using 454 next-generation deep-sequencing technologyIntegrated genomic profiling, therapy response, and survival in adult acute myelogenous leukemiaClassic Ras Proteins Promote Proliferation and Survival via Distinct Phosphoproteome Alterations in Neurofibromin-Null Malignant Peripheral Nerve Sheath Tumor Cells.Defining key signaling nodes and therapeutic biomarkers in NF1-mutant cancers.Diffuse large B cell lymphoma presenting as Horner's syndrome in a patient diagnosed with neurofibromatosis type 1: a case report and review of the literature.Comparative oncogenomics implicates the neurofibromin 1 gene (NF1) as a breast cancer driver.Integration of microarray analysis into the clinical diagnosis of hematological malignancies: How much can we improve cytogenetic testing?Targeting oncogenic Ras signaling in hematologic malignancies.Clonal evolution and devolution after chemotherapy in adult acute myelogenous leukemia.Induction of mitotic catastrophe by PKC inhibition in Nf1-deficient cellsmicroRNAs Make the Call in Cancer Personalized Medicine.A case report of acute myeloid leukemia and neurofibromatosis 1.Neurofibromatosis-1 gene deletions and mutations in de novo adult acute myeloid leukemia.Tissue-specific differences in the proportion of mosaic large NF1 deletions are suggestive of a selective growth advantage of hematopoietic del(+/-) stem cells.
P2860
Q27000577-646EDC37-7320-4518-9056-D1A1E09CB973Q28390558-5C62CDC8-E19F-47A3-A037-3C6985BC19F8Q33394269-460FEEA5-8F00-4608-97CD-DC6259F40D5BQ33815665-4B118405-ED72-4119-A099-A9CE70C6416EQ33823452-998100CB-3D08-4D7D-9AA8-010122D3FBBDQ34227509-F6B1F53B-9851-43C4-A6DF-144AA866F589Q34400180-66A2FD00-93A8-479F-A028-7CEFC7920DC0Q34450715-7946D29C-67F4-4269-B103-2988CEF79E2FQ34451050-25E6E2DD-7601-46C4-B872-DF19F0B8867BQ35081389-47EC7EE4-F445-4F60-B311-4469D1645A78Q35083685-198465D8-8738-4E60-A2C8-3DFF6FF2232BQ35562821-2F799886-FBC0-48CA-86CD-51FEEDD4962DQ35612406-FACC7E17-E958-4B41-8FF9-CE6E6404758BQ35657827-750542C9-70E5-4315-88BC-81370E21C589Q35858350-C7B7981B-CABA-4EEA-95F8-A38F2A9840D9Q36268076-EC4BCD3A-1166-4BBC-A7D6-951EF6AF197BQ36326271-19B95615-23B3-40BE-9169-0EF51D1215E7Q36352506-05CCD01C-7BDA-494F-A325-561774269CFCQ36842838-5327EC29-781A-47D6-AE8B-30FF7C15201AQ38931360-F77E0753-31EE-415E-9A46-AE5C1194937DQ42156325-B0847851-35BF-49DB-A8C8-733C903CCB5EQ43080898-430F10DD-96B4-478D-9A6C-A10FD22AF942Q43685374-7B20BE92-0AC5-42BA-9861-FB59F52BDEB0Q51833546-63C5D365-2D53-44DB-A57F-715170AD4CFE
P2860
description
2010 nî lūn-bûn
@nan
2010 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
NF1 inactivation in adult acute myelogenous leukemia
@ast
NF1 inactivation in adult acute myelogenous leukemia
@en
NF1 inactivation in adult acute myelogenous leukemia
@nl
type
label
NF1 inactivation in adult acute myelogenous leukemia
@ast
NF1 inactivation in adult acute myelogenous leukemia
@en
NF1 inactivation in adult acute myelogenous leukemia
@nl
prefLabel
NF1 inactivation in adult acute myelogenous leukemia
@ast
NF1 inactivation in adult acute myelogenous leukemia
@en
NF1 inactivation in adult acute myelogenous leukemia
@nl
P2093
P2860
P1476
NF1 inactivation in adult acute myelogenous leukemia
@en
P2093
Amanda Dressel
Ammar Al-Zoubi
Anjali Purkayastha
Diane Roulston
Harry Erba
Judith Karp
Kerby Shedden
Lisa Kujawski
Moshe Talpaz
P2860
P304
P356
10.1158/1078-0432.CCR-09-2639
P407
P50
P577
2010-05-26T00:00:00Z